Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

Gouty arthritis and kidney function outcomes and serum uric acid level variations in obese patients following bariatric surgery

The Egyptian Journal of Internal Medicine volume 34, Article number: 3 (2022) Cite this article

Abstract

Background

Obesity is an independent risk factor for chronic kidney disease (CKD) and is the strongest known modifiable risk factor for hyperuricemia and gout. We aimed to discover the outcome of serum uric acid (SUA), gouty arthritis, and kidney function in obese patients after bariatric surgery and possible links with BMI variations.

Methods

Retrospective study has been performed in National Hospital in Riyadh, KSA, between Jan. 2018 to Jan. 2020. We studied only 98 patients who met our inclusion criteria. Patients followed-up at 1 month (for gouty attack only) postoperative, 3 months postoperative, and 6 months postoperative for body mass index (BMI), serum creatinine, dipstick urinalysis, SUA, and estimated glomerular filtration rate (eGFR). Radiological studies, medical history, follow up radiological studies, and clinical follow up were obtained from the hospital data system.

Results

A total of 98 patients with mean eGFR were 90.65 ± 29.34 ml/min/1.73 m2, mean SUA 5.56 ± 1.84 mg/dl, and mean BMI was 45.28 ± 7.25 kg/m2, at surgery. Mean BMI had decreased significantly to 38.52 ± 6.05 kg/m2 at 3 months and to 34.61 ± 5.35 kg/m2 at 6 months (P < 0.001). The mean GFR had improved significantly (99.14 ± 23.32 ml/min/1.73 m2) at 6 months (P < 0.001). Interestingly, proteinuria had resolved in 17 patients out of 23 patients at 6 months. Number of gouty attacks was decreased during the first month post-surgery (P < 0.001). SUA level was significantly decreased (4.32 ± 1.27 mg/dl) (P < 0.001). SUA showed significant negative correlations with eGFR at 3 months and positively significant correlations with BMI at 3 and 6 months. By multinomial logistic regression, BMI and initial eGFR were the independent predictive variables for the outcome of eGFR at 6 months, while male gender and initial SUA were the independent predictive variables on the outcome of SUA at 6 months. Postoperatively in gouty arthritis patients, the number of joints affected, patient global VAS assessment, and number of gouty attacks were significantly reduced (P < 0.001).

Conclusion

Bariatric surgery has been associated with reduction of BMI and subsequently reduction of SUA levels, gouty attacks, and improvement of eGFR.

Introduction

Obesity is one of the most common preventable diseases [1], with multifactorial etiology [2]. Bariatric surgery has been considered the most reliable method of achieving long-term weight loss [3]. Bariatric surgery is associated with a significant decrease in body weight and serum uric acid (SUA) levels among people with obesity, with predominantly obvious reductions in those with hyperuricemia and gout [3]. However, few studies have reported on the longitudinal changes in uric acid levels after bariatric surgery [4]. Obesity is an independent risk factor for hyperuricemia and gout, particularly visceral adiposity, via both increased production and decreased renal excretion of uric acid [5]. CKD is an evolving noncommunicable disease of public health significance [6]. Obesity is well-defined as an independent risk factor for CKD incidence and its progression [7]. Morbid obesity is linked to glomerulosclerosis [8]. Renal diseases in the setting of obesity often manifest by proteinuria, glomerular hyperfiltration, and decreased glomerular filtration rate (GFR) [9]. Numerous studies have shown an association between obesity and both the development and the progression of CKD and extends to other complications such as nephrolithiasis and kidney malignancies [10, 11].

We aimed to discover the outcome of SUA, gouty arthritis, and kidney function in obese patients after bariatric surgery and in correlation with BMI variations.

Methods

Study design

Retrospective study had been performed in National Hospital in Riyadh, KSA, between Jan. 2018 to Jan. 2020. All the preoperative assessment and the postoperative follow-up data were collected from the hospital data base system. We studied 166 obese patients requiring surgical treatment for the first time (72 men, 94 women); only 98 patients (41 males and 57 females) were included and met our inclusion criteria. Biochemical parameters were done by obtaining blood samples after an overnight fast, included blood urea nitrogen (BUN), serum creatinine, serum uric acid (SUA), and eGFR by using modification diet for renal disease study equation (DMRD).

For gouty patients (35 patients), medication history and clinical examination (radiological follow-up if available) from the hospital system were collected; it was included, disease duration, number of joint affected, visual analog scale (VAS) patient global assessment (0‑100 score) [12], number of tophi seen in affected joints, and number of gouty attack before and 6 months after the operation.

Inclusion and exclusion criteria

Eligibility criteria included:

  1. (I)

    Age ranges from 18 to 65 years old

  2. (II)

    BMI more than 40 or more than 35 with associated high-risk family history of DM, and cardiovascular disease for which nonsurgical treatment failed

  3. (III)

    Any patient with history of DM, hypertension, chronic kidney disease, and any chronic disease was excluded from the study

  4. (IV)

    History of steroid therapy and/or thyroid dysfunction were excluded

  5. (V)

    Patients with history of previous bariatric surgery, debilitating disease, unresolved psychiatric illness, unable to follow-up, smoking, or substance abuse were excluded from the study

Follow-up

Patients followed-up at 1-month (for gouty attack only) postoperative, 3-month postoperative, and 6-month postoperative for BMI, serum creatinine, dipstick urine analysis for proteinuria, serum uric acid and eGFR, and clinical follow-up for gouty patients.

Statistical analysis

All data will be analyzed using the SPSS statistical software for Windows, version 21.0, data were expressed as means ± SD (number and percent for categorical data). Comparisons of continuous data were performed using an independent sample t test/pair t test or the Mann-Whitney U test where appropriate while categorical data were compared using chi-square test. Correlations between BMI and uric acid, arthritis outcome and eGFR were identified by using partial correlation analysis. Multinomial logistic regression analysis was performed to assess the independent predictive effects of the variables on variance of SUA and eGFR. P value less than 0.05 was considered significance.

Results

Clinical characteristics

At the surgery

Of the 98 patients, 57 (58.2%%) were female, the mean age was 33.28 ± 11.38 years, the mean BMI was 45.65 ± 7.25 kg/m2, the mean SUA was 5.56 ± 1.84 mg/dl, and the eGFR (using MDRD) was 90. 65 ± 29.34 mL/min/1.73 m2. Twenty-three patients (23.5%) had significant proteinuria (≥ 0.5 g/day) and 12 (12.24%) patients with history of recent gouty attack (Table 1).

Table 1 Demographic and laboratory data of the studied group at the surgery, after 3 months, and after 6 months
Full size table

At 3 months post-surgery

There was significant reduction in BMI, SUA, number of patient with proteinuria, and number of gouty attacks, and eGFR compared to the starting values(P < 0.001) (Table 1).

At 6 months post-surgery

There was significant reduction in BMI, SUA, number of patient with proteinuria and number of gouty attacks, and marked improvement of eGFR compared to the starting and after 3 months values (P < 0.001) (Table 1).

eGFR and serum uric acid variance during the study period

Of 98 patients, at the surgery, 51 (52%) patients had low eGFR (MDRD), 42 (42.86%) patients had normal eGFR and only 5 (5.1%) patients had abnormal high eGFR. After 3 month, 45 (45.9%) patients had low eGFR (MDRD), 51 (52%) had normal eGFR and only 3 (3.06%) patients had abnormal high eGFR (P < 0.001). After 6 month, 35 (35.7%) patients had low eGFR (MDRD), 60 (61.22%) had normal eGFR, and only 3 (3.06%) patients had abnormal high eGFR. There was significant improvement (normalization) (P < 0.001) of abnormal lower eGFR after 6 month post-surgery (Table 2). SUA level was decreased significantly during the study period (P < 0.001) and was correlated and linked to reduction in BMI and improvement in eGFR (Tables 1, 3, and 5).

Table 2 eGFR outcome in the studied group
Full size table
Table 3 Correlation between eGFRm, BMI, and serum UA in the studied group (Spearman correlation)
Full size table

Correlations

At the start and 3 months after surgery

SUA showed significant negative correlations with eGFR (MDRD) and significant positive correlations with BMI (Table 3).

At 6 months post-surgery

SUA showed significant positive correlations to BMI (Table 3) and no correlation with eGFR (MDRD) (Table 3). For eGFR (Cockcroft-Gault formula), there were positive correlations with serum creatinine and BMI and no any significant correlation with SUA.

Multinomial logistic regression

We found that only BMI and initial eGFR were the independent predictive variables on the outcome of eGFR at 6 months (P = 0.021 and < 0.001, respectively) (Table 4) and male gender and initial uric acid were the independent predictive variables on the outcome of SUA after 6 months (P = 0.046 and 0.049, respectively) (Table 5).

Table 4 Multinomial logistic regression for independent predictive variable on eGFR outcome
Full size table
Table 5 Multinomial logistic regression for independent predictive variable on SUA outcome
Full size table

Gouty arthritis patient group

The demographic, laboratory data, and clinical parameters were concised in Table 6; there were significant reduction in BMI, SUA, and serum creatinine, number of joints affected postoperative, VAS assessment postoperative, and number of gouty attacks postoperatively compared with preoperative state (P < 0.001) while there was significant improvement of eGFR and disappearance of joint tophi at 6 months postoperative. At 6 months postoperative, BMI reduction was positively correlated with SUA (P < 0.001) and with patient global assessment VAS score (P = 0.045), while postoperative gouty attack reduction was positively correlated with patient global VAS (P = 0.003) and with postoperative number of joint affected (P = 0.013). There was on noticed tophi deposition around the previously affected joints.

Table 6 Parameters gouty arthritis patient group
Full size table

Discussion

Bariatric surgery is associated with a major improvement in dyslipidemia, hypertension, urinary albumin excretion, quality of life, and with an important improvement in all parameter of kidney function [13,14,15]. Glomerulomegaly and focal glomerulosclerosis have been closely linked to obesity and may lead to initiation of glomerular hyperfiltration and deterioration of kidney functions [16].

In our study, a total of 98 patients with mean GFR 90.65 ml/min/1.73 m2, mean SUA 5.56 mg/dl, and mean BMI 45.28 kg/m2 before surgery. BMI had significantly decreased to 38.52 kg/m2 at 3 months and to 34.61 kg/m2 at 6 months (P < 0.001). The mean eGFR at 3 and 6 months of follow-up had improved significantly to > 90 (P < 0.001). Interestingly, proteinuria had resolved significantly in 17 patients out of 23 patients after 6 months (P < 0.001) (Table 1). Many studies showed that glomerular hyperfiltration caused by obesity reflected loss of renal functional reserve and shared to the progressive of CKD [17, 18]. Many studies confirm a beneficial relationship of bariatric surgery with long-term kidney function course using multiple filtration markers [19]. The significant association between bariatric surgery and improved kidney function trajectory in patients at lower baseline kidney function was consistent with other studies that only examined eGFRcr [20], as in our study, there was significant improvement of lowered eGFR followed to bariatric surgery (P < 0.001) (Table 2). Patient who failed to recover their eGFR, it was less than 60 mL/min/1.73 m2. By multinomial logistic regression, we found that only BMI and initial eGFR were the independent predictive variables on the outcome of eGFR at 6 months (P = 0.021 and < 0.001, respectively) (Table 4). It was clear that bariatric surgery obviously improved all major risk factors for kidney injury as well as parameters of kidney function (GFR, urinary protein excretion, but also may be linked to a major increase in risk of stone formation) [21]. Using of multiple filtration equation to show homogeneity of the association with improved kidney functions is a good, but we found that MDRD was more reliable than Cockcroft-Gault formula in obese patients. Education and awareness of the risks of obesity and a healthy lifestyle, including proper nutrition and exercise, can intensely help in preventing obesity and kidney disease [22].

Abdominal adiposity and obesity were linked to high risk of increasing gout [23]. Bariatric surgery has been related to decreased SUA levels and overall gout incidence. Weight loss showed beneficial effects on SUA and gout attacks [24, 25]. Increased SUA seems to be related to decreased eGFR [26, 27]. Our work showed that SUA had significantly decreased to 4.43 ± 1.22 mg/dl at 3 months and to and 4.32 ± 1.27 mg/dl at 6 months postoperative (Table 1) which were in line with a study reported that the incidence of SUA levels were decreased just 1 month postoperatively [28]. Although Dalbeth et al. [29] reported an increase in SUA 2 weeks after surgery and they suggested that it was due to renal dysfunction associated with major surgery, or metabolic effects from fasting or rapid weight loss (catabolic state), our work found that postoperative in gouty arthritis patients, the number of joints affected, VAS global assessment score, and number of gouty attacks were significantly reduced (P < 0.001) (Table 6) which was in line with other study [28] which linked this outcome to decreased BMI, SUA, and improved GFR. We reported that BMI reduction was positively correlated with SUA (P < 0.001) and with VAS global assessment score (P = 0.045), while postoperative gouty attack reduction was positively correlated with VAS (P = 0.003) and with postoperative number of joint affected (P = 0.013) (Table 6). There is a higher risk of gout attacks during the first month postoperative [30] mainly related to the changes in SUA, rather than absolute level [11] as dramatic changes in SUA levels might trigger gout attacks [31] as crystals may be shed back to the bloodstream and lead to the time-based increase of SUA and trigger acute gouty attack and the flare-up [3]. On the other hand, weight loss following bariatric surgery was found to be associated with reduced inflammatory responses to monosodium urate (MSU) crystals and significant reductions in many inflammatory cytokines [32] leading to significant reduction in the frequency of gout attacks [33, 34]. Others reported that the effect of bariatric surgery on SUA levels and the frequency of gout attacks vary in time after the surgery [28, 35]. Gout may be another indication for bariatric surgery in patients with obesity [3]. There is a relationship between SUA and gender. Males with a BMI over 27.5 kg/m2 were 16 times more likely to have gout attacks than males with a BMI < 20 kg/m2 [25]. In our study, males showed a greater decline in SUA than females and males had high mean SUA 8.15 ± 0.63 mg/dl while females have 7.17 ± 0.65 mg/dl at the start, but at 6 months postoperative; males had mean SUA 5.09 ± 1.40 mg/dl while females have mean SUA 5.18 ± 1.31 mg/dl. Males showed significant reduction in SUA by 93.33% 6 months after surgery, while in females showed 56.57% reduction (p < 0.001). By multinomial logistic regression, we found that male gender and initial uric acid were the independent predictive variables on the outcome of uric acid at 6 months (P = 0.046 and 0.049, respectively) (Table 5). Our results were supported by many studies [28, 36] and partially with others [37]. The study had weak points and limitations, being a retrospective study and short period of follow-up.

Conclusion

Bariatric surgery has a great and significant effect on patient outcome: marked improvement of eGFR and excellent reduction of SUA and improvement of gouty arthritis among obese patients.

Availability of data and materials

The data that support the finding of this study are available from the National Hospital in Riyadh, KSA, but restriction apply to the availability of the data which were used under license in the current study and local license from that hospital and so are not publicly available. Data are however available from the corresponding author upon reasonable request and with permission from the National Hospital.

References

  1. Baetge C, Earnest CP, Lockard B et al (2017) Efficacy of a randomized trial examining commercial weight loss programs and exercise on metabolic syndrome in overweight and obese women. Appl Physiol Nutr Metab 42(2):216-227.

  2. Jukaku SA, Williams SRP (2021) The cause of obesity is multifactorial but GPs can do more. BMJ 373:n956. https://doi.org/10.1136/bmj.n95.

  3. Lu J, Bai Z, Chen Y et al (2021) Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis. Rheumatology. https://doi.org/10.1093/rheumatology/keaa822

  4. Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693

    Article  Google Scholar 

  5. Rathmann W, Funkhouser E, Dyer AR et al (1998) Relations of hyperuricaemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary artery risk development in young adults. Ann Epidemiol 8(4):250–261

    Article  CAS  Google Scholar 

  6. Rai PK, Jindal PK, Rai P et al (2014) Screening of chronic kidney disease (CKD) in general population on world kidney day on three consecutive years: a single day data. Int J Med Public Health 4:167–170

    Article  Google Scholar 

  7. Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee (2017) Obesity and kidney disease: hidden consequences of the epidemic. Nephron 135:243–251

    Article  Google Scholar 

  8. Kambham N, Markowitz GS, Valeri AM, Lin J et al (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509

    Article  CAS  Google Scholar 

  9. Serra A, Romero R, Lopez D et al (2008) Renal injury in the extremely obese patients with normal renal function. Kidney Int 73:947–955

    Article  CAS  Google Scholar 

  10. Brolin RE (2002) Bariatric surgery and long-term control of morbid obesity. JAMA 288:2793–2796

    Article  Google Scholar 

  11. Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366(17):1577–1585

    Article  CAS  Google Scholar 

  12. Hawker GA, Mian S, Kendzerska T et al (2011) Measures of adult pain visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res 63(S11):S240–SS25

    Article  Google Scholar 

  13. Navaneethan SD, Kelly KR, Sabbagh F et al (2010) Urinary albumin excretion, HMWadiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 20(3):308–315. https://doi.org/10.1007/s11695-009-0026-1.

  14. Habib P, Scrocco JD, Terek M et al (2009) Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol 104:1251–1255

    Article  CAS  Google Scholar 

  15. Ahmed MH, Byrne CD (2010) Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrol Dial Transplant 25:3142–3147

    Article  Google Scholar 

  16. Li K, Zou J, Ye Z et al (2016) Effects of bariatric surgery on renal function in obese patients: a systematic review and meta-analysis. PLOS ONE  11(10):e0163907.

  17. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW (2012) Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8:293–300

    Article  CAS  Google Scholar 

  18. Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J et al (2008) Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 23:3946–3952

    Article  CAS  Google Scholar 

  19. Chang AR, Wood C, Chu X et al (2020) Association of bariatric surgery with rates of kidney function decline using multiple filtration markers. JAMA Netw Open 3(9):e2014670

    Article  Google Scholar 

  20. Chang AR, Chen Y, Still C et al (2016) Bariatric surgery is associated with improvement in kidney outcomes. Kidney Int 90(1):164–171

    Article  Google Scholar 

  21. Navaneethan SD, Yehnert H (2009) Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis 5:662–665

    Article  Google Scholar 

  22. Kovesdy CP, Susan L, Zoccali C (2017) Obesity and kidney disease: hidden consequences of the epidemic. J Ren Nutr 27(2):75–77

    Article  Google Scholar 

  23. Chen JH, Pan WH, Hsu CC et al (2013) Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study. Arthritis Care Res 65(1):133–140

    Article  Google Scholar 

  24. Hui M, Carr A, Cameron S et al (2017) The British Society for Rheumatology Guideline for the management of gout. Rheumatology. 56(7):1056–1059

    Article  CAS  Google Scholar 

  25. Williams PT (2008) Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 87(5):1480–1487

    Article  CAS  Google Scholar 

  26. Kang EH, Lee EY, Lee YJ et al (2008) Clinical features and risk factors of postsurgical gout. Ann Rheum Dis 67(9):1271–1275

    Article  CAS  Google Scholar 

  27. Friedman JE, Dallal RM, Lord JL (2008) Gouty attacks occur frequently in postoperative gastric bypass patients. Surg Obes Relat Dis 4(1):11–13

    Article  Google Scholar 

  28. Raziel A (2018) Gout, obesity and bariatric surgery. Adv Obes Weight Manag Control 8(4):224–229

    Google Scholar 

  29. Dalbeth N, Chen P, White M et al (2014) Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study. Ann Rheum Dis 73(5):797–802

    Article  CAS  Google Scholar 

  30. Sjostrom L, Narbro K, Sjostrom CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357(8):741–752

    Article  Google Scholar 

  31. Nielsen SM, Bartels EM, Henriksen M et al (2017) Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis 76(11):1870–1882

    Article  Google Scholar 

  32. Dalbeth N, Pool B, Yip S (2013) Effect of bariatric surgery on the inflammatory response to monosodium urate crystals: a prospective study. Ann Rheum Dis 72(9):1583–1584

    Article  Google Scholar 

  33. Chen JH, Lee CH, Chang CM et al (2016) Successful management of new- onset diabetes mellitus and obesity with the use of laparoscopic sleeve gastrectomy after kidney transplantation-a case report. Transplant Proc 48(3):938–939

    Article  CAS  Google Scholar 

  34. Schiavo L, Favrè G, Pilone V et al (2018) Low-purine diet is more effective than normal-purine diet in reducing the risk of gouty attacks after sleeve gastrectomy in patients suffering of gout before surgery: a retrospective study. Obes Surg 28(5):1263–1270

    Article  Google Scholar 

  35. Romero-Talamás H, Daigle CR, Aminian A et al (2014) The effect of bariatric surgery on gout: a comparative study. Surg Obes Relat Dis 10(6):1161–1165

    Article  Google Scholar 

  36. Zhang Q, Lou S, Meng Z et al (2011) Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese. Clin Rheumatol 30:777–787

    Article  Google Scholar 

  37. Liu W, Zhang H, Han X, Zhang P, Mao Z (2019) Uric acid level changes after bariatric surgery in obese subjects with type 2 diabetes mellitus. Ann Transl Med 7(14):332

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

Not applicable

Author information

Authors and Affiliations

  1. Physical Medicine, Rheumatology, and Rehabilitation Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Mona G. Balata

  2. Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Ahmed H. Helal

  3. Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Ashraf H. Mohamed, Alaa-Uddin Habib, Mahmoud Awad & Mohamed Sherif

Authors
  1. Mona G. Balata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmed H. Helal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashraf H. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alaa-Uddin Habib
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mahmoud Awad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohamed Sherif
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M. S. Sharing idea of the study, data analysis, writing discussion and publication. M.G. Sharing idea of the study, data collection and processing, result and discussion writing. A. H. Sharing idea of the study, data analysis, writing discussion and publication. A. H. Sharing idea of the study, data collection and processing, result and discussion writing. M. A. Sharing idea of the study, data analysis, writing discussion and publication. A. M. Sharing idea of the study, data collection and processing, data analysis, result and discussion writing. All authors read, reviewed, and approved the manuscript.

Corresponding author

Correspondence to Ashraf H. Mohamed.

Ethics declarations

Consent to participate

Not applicable (retrospective study)

Ethics approval and consent to participate

The study was approved by the scientific and ethical committee in National Hospital, Riyadh, on February 2021.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Balata, M.G., Helal, A.H., Mohamed, A.H. et al. Gouty arthritis and kidney function outcomes and serum uric acid level variations in obese patients following bariatric surgery. Egypt J Intern Med 34, 3 (2022). https://doi.org/10.1186/s43162-021-00091-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43162-021-00091-8

Keywords